FINDINGS OF SCIENTIFIC MISCONDUCT

RELEASE DATE:  April 5, 2004

NOTICE:  NOT-OD-04-038

Department of Health and Human Services (DHHS)

Notice is hereby given that the Office of Research Integrity (ORI) and 
the Acting Assistant Secretary for Health have taken final action in 
the following case:

Vickie L. Hanneken, R.N., Decatur Memorial Hospital:  Based on the 
report of an investigation conducted by Decatur Memorial Hospital (DMH) 
and additional analysis conducted by the Office of Research Integrity 
in its oversight review, the U.S. Public Health Service (PHS) found 
that Vickie L. Hanneken, R.N., former Clinical Research Associate, DMH, 
engaged in scientific misconduct in research that was part of a 
Southwest Oncology Group prostate cancer prevention clinical trial 
supported by a National Cancer Institute (NCI), National Institutes of 
Health (NIH), cooperative agreement U10 CA45807 under the Central 
Illinois Clinical Community Oncology Program.

PHS found that the Respondent engaged in scientific misconduct by 
falsifying or fabricating data in the clinical/study records of 35 
participants in the Selenium and Vitamin E Cancer Prevention Trial 
(SELECT) at Decatur Memorial Hospital, with a total of 60 separate 
acts, which included:

1.  falsification of the laboratory reports on PSA concentration for 12 
participants;
2.  fabrication of the laboratory reports on PSA concentration for 2 
participants;
3.  falsification of the physician’s and nurse’s records for 10 
participants;
4.  fabrication of the nurse’s records for 2 participants;
5.  falsification of data on patients’ history and physical forms for 
21 participants; and 
6.  entry of falsified data into the SWOG computerized data base for 13 
participants.

Ms. Hanneken has entered into a Voluntary Exclusion Agreement 
(Agreement ) in which she has voluntarily agreed for a period of three 
(3) years, beginning on March 15, 2004:

(1)  to exclude herself from any contracting or subcontracting with any 
agency of the United States Government and from eligibility or 
involvement in nonprocurement programs of the United States Government 
as defined in the debarment regulations at 45 C.F.R. Part 76; and

(2)  to exclude herself from serving in any advisory capacity to PHS 
including but not limited to service on any PHS advisory committee, 
board, and/or peer review committee, or as a consultant.

INQUIRIES

For further information contact:

Director
Division of Investigative Oversight
Office of Research Integrity
1101 Wootton Parkway, Suite 750
Rockville, MD  20852
Telephone:  301-443-5330


Return to Volume Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.